Published date: Aug 04 2023

Journal Title: KnE Social Sciences

Issue title: International Conference Health, Social Science & Engineering (ICHSSE 2022)

Pages: 123–129

DOI: 10.18502/kss.v8i14.13825

Ernawati Ernawatiernawatisujono78@gmail.comFaletehan University Serang

Isnaini NurhayatiSTIKes Mambaul Ulum Surakarta

Follow-up events post-Covid-19 Vaccine (KIPI) is one of a person’s considerations in deciding whether or not to participate in the Covid-19 vaccine. Adverse events after the Covid-19 vaccine vary widely, several studies have been carried out to look at the characteristics of AEFI after the Covid-19 vaccine. Several things still require study, one of which is the AEFI category for survivors and non-survivors. This study aims to describe the characteristics of post-vaccine adverse events, as well as the AEFI categories for survivors and non-survivors after the Covid-19 vaccine is given. The research design is descriptive with a cross-sectional research method. The research subjects were 128 people in the West Banten Region who had received the Covid-19 vaccine. The data were obtained by using Google-form which had been shared through WhatsApp groups. This research was conducted in December 2021. The data collection technique used in this study was random sampling. The results showed 8 respondents who complained of post-vaccine fever (6.3), 14 complained of dizziness after the vaccine (10.9), 31 complained of muscle pain (24.2), 2 complained of shortness of breath after getting the vaccine (1.2), 2 complained of nausea after getting the vaccine (1.6), and 4 complained of itching all over the body (3,4). The majority of research respondents experienced mild AEFI in both the survivors and the non-survivors. Information related to the lightness of AEFI after the covid vaccine is a mandatory consumption material that must be given to the community; besides that, it can also be used as a basis for the government to set policies.

Keywords: AEFI, survivors and non-survivors, COVID-19 vaccine

[1] Safira M, Peranginangin M, Saputri GAR. Evaluasi Monitoring Kejadian Ikutan Pasca Imunisasi (KIPI) Vaksin Covid-19 (Coronavac) pada Tenaga Kesehatan di Rumah Sakit Imanuel Bandar Lampung. Jurnal Mandala Pharmacon Indonesia. 2021;7(2):251–262.

[2] Sutari S, Idris H, Misnaniarti M. Implementasi kebijakan vaksinasi covid-19 di Indonesia: narrative review. Riset Informasi Kesehatan. 2022;11(1):71–81.

[3] Widayanti LP, Kusumawati E. Hubungan persepsi tentang efektifitas vaksin dengan sikap kesediaan mengikuti vaksinasi Covid-19. Jurnal Hearty: Jurnal Kesehatan Masyarakat. 2021;9(2):78–85.

[4] Abdullah RPI, Zulfahmidah Z, Abdullah SS. Penyuluhan Vaksin COVID-19 dan Protokol Pencegahan COVID-19 di Masa Kenormalan Baru (New Normal) serta Pendistribusian Apd di Desa Paddinging, Takalar. J Pengabdian Kedokteran Indo. 2022;3(1):1–6.

[5] Unicef. Hal-hal yang perlu diketahui sebelum, saat, dan setelah menerima vaksin COVID-19| UNICEF Indonesia. 2021. Diperoleh dari https://www unicef org/indonesia/id/coronavirus/hal-hal-yang-perlu-diketahui-sebelum-saat-dansetelah- menerima-vaksin-covid-19.

[6] Safira M, Peranginangin M, Saputri GAR. Evaluasi monitoring kejadian ikutan pasca imunisasi vaksin Covid-19. J Mandala Pharmacon Indo. 2021;7(2):251–262.

[7] Romlah SN, Darmayanti D. Kejadian ikutan pasca imunisasi (KIPI) vaksin Covid-19. Holistik Jurnal Kesehatan. 2022;15(4):700–712.

[8] Yari Y, Oktianingsih T, Gita I, Luanda D, Fredy MK, Kurniawan W, et al. Deskripsi Tingkat Kecemasan Perawat Saat Bertugas di Ruang Perawatan Covid-19. J Nurs Educ Pract. 2021;1(01):5–9.